1 active not recruiting, 1 not yet recruiting, 1 recruiting, 1 unknown. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Unknown 1 |
Follow Li-kun Chen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Brain Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (2) · Lung Neoplasms (2) · Meningeal Carcinomatosis (1) · Recurrence (1)
Bevacizumab (1) · anlotinib (1) · aumolertinib (1)
China (3)
Likun Chen (1)